Manulife (Manufacturers Life Insurance)’s Abivax ABVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.3M Buy
38,595
+3,063
+9% +$362K ﹤0.01% 1203
2025
Q4
$4.92M Buy
35,532
+9,396
+36% +$1.03M ﹤0.01% 1177
2025
Q3
$2.22M Buy
+26,136
New +$1.6M ﹤0.01% 1476

Other funds holding ABVX

Manulife (Manufacturers Life Insurance)'s ABVX Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Abivax (ABVX) stake by 8.6% in Q1 2026, buying an estimated $362K and bringing the position to 38,595 shares worth $4.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1203.

Manulife (Manufacturers Life Insurance) first reported a position in ABVX in Q3 2025 and has held it in 3 quarters since. The position peaked at $4.92M in Q4 2025. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 38,595 shares of Abivax worth $4.3M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) bought 3,063 Abivax shares in Q1 2026, an estimated $362K.
  • Abivax made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1203 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Abivax in Q3 2025 and has held it in 3 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Abivax position peaked at $4.92M in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.